You are here: Home » Current Affairs » News » National
Business Standard

Top headlines: Omicron variant scare; GDP passes pre-Covid level

Vaccine makers in India say they can scale up production to deal with new crises. More on that in our top headlines.

Coronavirus Vaccine | Coronavirus | GDP

BS Web team 

Photo: Bloomberg
Photo: Bloomberg

The World Health Organization warned countries not to impose blanket travel bans over the new Omicron variant. Vaccine makers in India say they can scale up production to deal with fresh outbreaks. More on those stories in our top headlines.

Firms give vaccine reassurance for Omicron; WHO advises against travel bans

The World Health Organization warned countries on Tuesday not to impose blanket travel bans over the new Omicron variant as governments and scientists try to determine how much protection current vaccines would offer against the strain. Read more

Companies gear up for Omicron version of vaccines

As the Omicron variant of Sars-CoV-2 takes centre stage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible. Ahmedabad-based Zydus Cadila is making a DNA vaccine using the Omicron sequence, but will not immediately take it to the clinic. Read more

India's passes pre-Covid level, but by a tad; France still 0.4% below

India’s gross domestic product (GDP) has crept higher than it was before the Covid-19 pandemic. The September quarter numbers show India’s real at Rs 35.73 trillion.

This is 8.4 per cent higher than it was in September 2020. The previous year suffered from the pandemic lockdowns and its effects. Read more

probe found liabilities swelling, but capital eroding rapidly at RCap

The Reserve Bank of India’s (RBI’s) action on Reliance Capital (RCL) stems from several factors that were long in the making. Defaults apart, the central bank’s inspection found that the firm had liabilities more than three times the permissible limit. Its capital, in terms of a certain benchmark, had reduced to about one-third of the regulatory requirement. Read more

November show worst for Sensex and Nifty indices since March 2020

The benchmark BSE Sensex and Nifty indices fell nearly 4 per cent in November, marking their worst monthly performance since March 2020, when countries were imposing lockdowns to check the spread of the Covid-19 pandemic. Back then, the two benchmark indices had plunged 23 per cent each. Read more

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, December 01 2021. 08:29 IST